Literature DB >> 9409833

Drosophila male-specific lethal-2 protein: structure/function analysis and dependence on MSL-1 for chromosome association.

L M Lyman1, K Copps, L Rastelli, R L Kelley, M I Kuroda.   

Abstract

MSL-2 is required for the male-specific assembly of a dosage compensation regulatory complex on the X chromosome of Drosophila melanogaster. We found that MSL-2 binds in a reproducible, partial pattern to the male X chromosome in the absence of MLE or MSL-3, or when ectopically expressed at a low level in females. Moreover, the pattern of MSL-2 binding corresponds precisely in each case to that of MSL-1, suggesting that the two proteins function together to associate with the X. Consistent with this hypothesis, we isolated EMS-induced loss of function msl-1 and msl-2 alleles in a screen for suppressors of the toxic effects of MSL-2 expression in females. We also used site-directed mutagenesis to determine the importance of the MSL-2 RING finger domain and second cysteine-rich motif. The mutations, including those in conserved zinc coordinating cysteines, confirm that the RING finger is essential for MSL-2 function, while suggesting a less stringent requirement for an intact second motif.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409833      PMCID: PMC1208343     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  72 in total

1.  Structure and distribution of the Notch protein in developing Drosophila.

Authors:  S Kidd; M K Baylies; G P Gasic; M W Young
Journal:  Genes Dev       Date:  1989-08       Impact factor: 11.361

Review 2.  Gene dosage compensation in Drosophila melanogaster.

Authors:  J C Lucchesi; J E Manning
Journal:  Adv Genet       Date:  1987       Impact factor: 1.944

Review 3.  Compartments and appendage development in Drosophila.

Authors:  S S Blair
Journal:  Bioessays       Date:  1995-04       Impact factor: 4.345

4.  Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.

Authors:  H D Bakker; H R Scholte; C Van den Bogert; W Ruitenbeek; J A Jeneson; R J Wanders; N G Abeling; B Dorland; R C Sengers; A H Van Gennip
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

Review 5.  On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective.

Authors:  L P Freedman; B F Luisi
Journal:  J Cell Biochem       Date:  1993-02       Impact factor: 4.429

Review 6.  Dosage compensation in Drosophila.

Authors:  B S Baker; M Gorman; I Marín
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

7.  The TAF(II)250 subunit of TFIID has histone acetyltransferase activity.

Authors:  C A Mizzen; X J Yang; T Kokubo; J E Brownell; A J Bannister; T Owen-Hughes; J Workman; L Wang; S L Berger; T Kouzarides; Y Nakatani; C D Allis
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

8.  Male-specific lethal mutations of Drosophila melanogaster.

Authors:  J M Belote; J C Lucchesi
Journal:  Genetics       Date:  1980-09       Impact factor: 4.562

9.  Molecular cloning and transcript mapping of the dihydroorotate dehydrogenase dhod locus of Drosophila melanogaster.

Authors:  W K Jones; R Kirkpatrick; J M Rawls
Journal:  Mol Gen Genet       Date:  1989-11

10.  Sex determination and dosage compensation in Drosophila melanogaster: production of male clones in XX females.

Authors:  L Sánchez; R Nöthiger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  70 in total

1.  Targeting the chromatin-remodeling MSL complex of Drosophila to its sites of action on the X chromosome requires both acetyl transferase and ATPase activities.

Authors:  W Gu; X Wei; A Pannuti; J C Lucchesi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

2.  Histone acetylation and gene expression analysis of sex lethal mutants in Drosophila.

Authors:  U Bhadra; M Pal-Bhadra; J A Birchler
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

3.  Functional integration of the histone acetyltransferase MOF into the dosage compensation complex.

Authors:  Violette Morales; Tobias Straub; Martin F Neumann; Gabrielle Mengus; Asifa Akhtar; Peter B Becker
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

Review 4.  Divergent actions of long noncoding RNAs on X-chromosome remodelling in mammals and Drosophila achieve the same end result: dosage compensation.

Authors:  Subhash C Lakhotia
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

Review 5.  Dosage compensation, the origin and the afterlife of sex chromosomes.

Authors:  Jan Larsson; Victoria H Meller
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

6.  The MLE subunit of the Drosophila MSL complex uses its ATPase activity for dosage compensation and its helicase activity for targeting.

Authors:  Rosa Morra; Edwin R Smith; Ruth Yokoyama; John C Lucchesi
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

7.  Transcription-coupled methylation of histone H3 at lysine 36 regulates dosage compensation by enhancing recruitment of the MSL complex in Drosophila melanogaster.

Authors:  Oliver Bell; Thomas Conrad; Jop Kind; Christiane Wirbelauer; Asifa Akhtar; Dirk Schübeler
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

8.  Cotranscriptional recruitment of the dosage compensation complex to X-linked target genes.

Authors:  Jop Kind; Asifa Akhtar
Journal:  Genes Dev       Date:  2007-08-15       Impact factor: 11.361

9.  Species-specific positive selection of the male-specific lethal complex that participates in dosage compensation in Drosophila.

Authors:  Monica A Rodriguez; Danielle Vermaak; Joshua J Bayes; Harmit S Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  The Drosophila dosage compensation complex binds to polytene chromosomes independently of developmental changes in transcription.

Authors:  I V Kotlikova; O V Demakova; V F Semeshin; V V Shloma; L V Boldyreva; M I Kuroda; I F Zhimulev
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.